MS
Mohan Sai Sundar Reddy Devarapalli
About Mohan Sai Sundar Reddy Devarapalli
Data last updated:
Mohan Sai Sundar Reddy Devarapalli is a Director at Reddys Therapeutics Private Limited (since 2025). The company operates in Healthcare. Reddys Therapeutics Private Limited reported revenue of ₹5.9 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2025 | 2016 | ₹5.9 Lakh (FY 2022) | Active |
Board colleagues of Mohan Sai Sundar Reddy Devarapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohan Reddy Enaganuri | 02720838 | Reddys Therapeutics Private Limited | Director |
| Rebala Rupakala | 07623584 | Reddys Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohan Sai Sundar Reddy Devarapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohan Sai Sundar Reddy Devarapalli
Mohan Sai Sundar Reddy Devarapalli currently holds 1 directorship: Reddys Therapeutics Private Limited (Director, since 20 Mar 2025, revenue ₹5.9 Lakh (FY 2022)).
Mohan Sai Sundar Reddy Devarapalli was first appointed on 20 Mar 2025 as Director at Reddys Therapeutics Private Limited.
The current boards of Mohan Sai Sundar Reddy Devarapalli's companies include Mohan Reddy Enaganuri (Reddys Therapeutics Private Limited), Rebala Rupakala (Reddys Therapeutics Private Limited).